SCHEMBL8965974

SCHEMBL8965974

COc1ccccc1COc1ccc(N)nn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.51
ABCB1 P08183 2/20 0.47
TLR8 Q9NR97 1/20 0.45
TLR7 Q9NYK1 1/20 0.45
HTR1A P08908 1/20 0.45
ADRA1D P25100 1/20 0.45
ADRA1A P35348 1/20 0.45
ADRA1B P35368 1/20 0.45
TAAR1 Q96RJ0 1/20 0.44
BCAT2 O15382 1/20 0.42
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
PARP14 Q460N5 1/20 0.40
PARP10 Q53GL7 1/20 0.40
PTGDR Q13258 1/20 0.40
CYP1A2 P05177 1/20 0.40
SGMS2 Q8NHU3 1/20 0.40
POLB P06746 1/20 0.40
AOC3 Q16853 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8966305 0.87 ABCB1 (0.49) ABCB1HTR1AADRA1DADRA1AADRA1B
SCHEMBL8966010 0.81 BCAT2 (0.45) BCAT2ALDH1A1GAAMAPTSGMS2
SCHEMBL8966341 0.81 IDO1 (0.55) IDO1ADRA1ATAAR1ALDH1A1MAPT
SCHEMBL8966253 0.78 BCAT2 (0.41) IDO1BCAT2ALDH1A1GAAMAPT
SCHEMBL8965872 0.76 BCAT2 (0.46) BCAT2ALDH1A1
SCHEMBL8965864 0.76 CNR1 (0.47) BCAT2MAPTPARP10CYP1A2POLB
SCHEMBL10480597 0.76 BCAT2 (0.58) BCAT2ALDH1A1POLBSMN1; SMN2
SCHEMBL8966278 0.75 HSP90AA1 (0.43) ABCB1ALDH1A1SMN1; SMN2
SCHEMBL8965564 0.75 TUBB1 (0.48) ABCB1ALDH1A1
SCHEMBL10531833 0.74 IDO1 (0.46) IDO1ABCB1TLR8TLR7HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5538970-A Treatment of cancer with imidazo-1,2-pyridazin compounds GLAXO WELLCOME INC. (US) 1996-07-23 US disclosed
US-5447956-A Anticarcinogenic agents BURROUGHS WELLCOME CO. (US) 1995-09-05 US disclosed
US-5380759-A Methyl N-[6-(3,4,5-trimethoxybenzloxy)imidazo[1,2-b]pyridazin-2-zyl]carbamate used to treat leukemia BURROUGHS WELLCOME CO. (US) 1995-01-10 US disclosed
US-5371219-A Antitumor agents BURROUGHS WELLCOME CO. (US) 1994-12-06 US disclosed
EP-0305093-B1 Imidazo(1,2-b)pyridazine derivatives WELLCOME FOUND (GB) 1994-04-06 EP disclosed
US-5091531-A Antitumor agents BURROUGHS WELLCOME CO. (US) 1992-02-25 US disclosed
EP-0305093-A1 Imidazo(1,2-b)pyridazine derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1989-03-01 EP disclosed